1. Home
  2. EYPT vs MYTE Comparison

EYPT vs MYTE Comparison

Compare EYPT & MYTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • MYTE
  • Stock Information
  • Founded
  • EYPT 1987
  • MYTE 2006
  • Country
  • EYPT United States
  • MYTE Germany
  • Employees
  • EYPT N/A
  • MYTE N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • MYTE Catalog/Specialty Distribution
  • Sector
  • EYPT Industrials
  • MYTE Consumer Discretionary
  • Exchange
  • EYPT Nasdaq
  • MYTE Nasdaq
  • Market Cap
  • EYPT 594.5M
  • MYTE 650.6M
  • IPO Year
  • EYPT 2005
  • MYTE 2021
  • Fundamental
  • Price
  • EYPT $7.48
  • MYTE $9.47
  • Analyst Decision
  • EYPT Strong Buy
  • MYTE Buy
  • Analyst Count
  • EYPT 8
  • MYTE 2
  • Target Price
  • EYPT $25.71
  • MYTE $4.88
  • AVG Volume (30 Days)
  • EYPT 922.9K
  • MYTE 107.3K
  • Earning Date
  • EYPT 03-06-2025
  • MYTE 02-13-2025
  • Dividend Yield
  • EYPT N/A
  • MYTE N/A
  • EPS Growth
  • EYPT N/A
  • MYTE N/A
  • EPS
  • EYPT N/A
  • MYTE N/A
  • Revenue
  • EYPT $45,713,000.00
  • MYTE $953,698,416.00
  • Revenue This Year
  • EYPT N/A
  • MYTE $10.88
  • Revenue Next Year
  • EYPT N/A
  • MYTE $9.72
  • P/E Ratio
  • EYPT N/A
  • MYTE N/A
  • Revenue Growth
  • EYPT 7.50
  • MYTE 9.97
  • 52 Week Low
  • EYPT $6.90
  • MYTE $2.41
  • 52 Week High
  • EYPT $30.99
  • MYTE $9.55
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 44.49
  • MYTE 77.04
  • Support Level
  • EYPT $7.15
  • MYTE $7.16
  • Resistance Level
  • EYPT $8.25
  • MYTE $7.84
  • Average True Range (ATR)
  • EYPT 0.66
  • MYTE 0.52
  • MACD
  • EYPT -0.01
  • MYTE 0.16
  • Stochastic Oscillator
  • EYPT 22.01
  • MYTE 96.98

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About MYTE MYT Netherlands Parent B.V. each representing one

MYT Netherlands Parent BV is a luxury e-commerce platform. The company offers luxury fashion wear for men, women, and kids. Also, the company sells shoes, bags, and accessories. The company operates in two segments which include the online segment and Retail store segments in which the majority of its revenue is generated from the Online segment.

Share on Social Networks: